Literature DB >> 24449507

miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells.

Jin Wang1, Guoxing Xu, Feng Shen, Yifan Kang.   

Abstract

In this study, we investigated the roles of miR-132 in tumor growth of osteosarcoma. We found that overexpression of miR-132 significantly suppressed in vitro cell proliferation and in vivo tumor growth. In addition, miR-132 overexpression induced G1/S cell cycle arrest of osteosarcoma cells. Further study showed that miR-132 could interact with the 3'-untranslated region of cyclin E1 (CCNE1) gene and repress its expression. Re-expression of CCNE1 (without the 3'UTR) could partially abrogate the miR-132-induced cell proliferation inhibition. Of significance, contrary to CCNE1, expression level of miR-132 was significantly lower in osteosarcoma tissues than in the adjacent normal tissues. Taken together, these results indicate that miR-132 functions as a tumor suppressor in osteosarcoma and that its suppressive effects are mediated chiefly by repressing CCNE1 expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24449507     DOI: 10.1007/s13277-014-1637-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  25 in total

1.  DNA methylation silences miR-132 in prostate cancer.

Authors:  A Formosa; A M Lena; E K Markert; S Cortelli; R Miano; A Mauriello; N Croce; J Vandesompele; P Mestdagh; E Finazzi-Agrò; A J Levine; G Melino; S Bernardini; E Candi
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

2.  miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.

Authors:  Gangxiong Huang; Kazumasa Nishimoto; Zhichao Zhou; Dennis Hughes; Eugenie S Kleinerman
Journal:  Cancer Res       Date:  2011-12-20       Impact factor: 12.701

3.  Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.

Authors:  Shuyu Zhang; Jun Hao; Fang Xie; Xiangui Hu; Cong Liu; Jian Tong; Jundong Zhou; Jinchang Wu; Chenghao Shao
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

4.  miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1.

Authors:  Jintang Xia; Zhiqiang Wu; Chunping Yu; Weiling He; Haiqing Zheng; Yulong He; Weihua Jian; Lianzhou Chen; Luanjing Zhang; Wen Li
Journal:  J Pathol       Date:  2012-05-23       Impact factor: 7.996

5.  Cyclin E1 is amplified and overexpressed in osteosarcoma.

Authors:  William W Lockwood; Deirdre Stack; Thomas Morris; David Grehan; Conor O'Keane; Greg L Stewart; Joanna Cumiskey; Wan L Lam; Jeremy A Squire; David M Thomas; Maureen J O'Sullivan
Journal:  J Mol Diagn       Date:  2011-03-31       Impact factor: 5.568

6.  MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell.

Authors:  Zhu Jianwei; Liu Fan; Liu Xiancheng; Bai Enzhong; Li Shuai; Li Can
Journal:  Tumour Biol       Date:  2013-06-06

7.  Chromosomal mapping of the genes for the human cell cycle proteins cyclin C (CCNC), cyclin E (CCNE), p21 (CDKN1) and KAP (CDKN3).

Authors:  D J Demetrick; S Matsumoto; G J Hannon; K Okamoto; Y Xiong; H Zhang; D H Beach
Journal:  Cytogenet Cell Genet       Date:  1995

8.  miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma.

Authors:  Cheng-Kui Cai; Guang-Yi Zhao; Li-Ying Tian; Lie Liu; Kang Yan; Yun-Lei Ma; Zhen-Wei Ji; Xiao-Xiang Li; Kang Han; Jie Gao; Xiu-Chun Qiu; Qing-Yu Fan; Tong-Tao Yang; Bao-An Ma
Journal:  Oncol Rep       Date:  2012-08-24       Impact factor: 3.906

9.  MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.

Authors:  Jinsong Li; Hongzhang Huang; Lijuan Sun; Mei Yang; Chaobin Pan; Weiliang Chen; Donghui Wu; Zhaoyu Lin; Chunxian Zeng; Yandan Yao; Peter Zhang; Erwei Song
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

Review 10.  Prognostic factors in osteosarcoma: a critical review.

Authors:  A M Davis; R S Bell; P J Goodwin
Journal:  J Clin Oncol       Date:  1994-02       Impact factor: 44.544

View more
  29 in total

1.  LncRNA SNHG5 affects cell proliferation, metastasis and migration of colorectal cancer through regulating miR-132-3p/CREB5.

Authors:  Mingbao Zhang; Yue Li; Hongbo Wang; Weihua Yu; Sen Lin; Jianqiang Guo
Journal:  Cancer Biol Ther       Date:  2018-11-05       Impact factor: 4.742

2.  miR-132 suppresses the migration and invasion of lung cancer cells by blocking USP9X-induced epithelial-mesenchymal transition.

Authors:  Huihui Guo; Xilin Zhang; Qiuqiang Chen; Ying Bao; Chaohui Dong; Xiang Wang
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

3.  miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b.

Authors:  Qing Liu; Zhenting Wang; Xiaohua Zhou; Mingying Tang; Wei Tan; Tianshi Sun; Youwen Deng
Journal:  Cell Cycle       Date:  2019-10-10       Impact factor: 4.534

4.  MicroRNA-132 suppresses cell proliferation in human breast cancer by directly targeting FOXA1.

Authors:  Dan Wang; Jin Ren; Hui Ren; Jin-Ling Fu; Dan Yu
Journal:  Acta Pharmacol Sin       Date:  2017-08-17       Impact factor: 6.150

5.  MicroRNA-132 enhances transition from inflammation to proliferation during wound healing.

Authors:  Dongqing Li; Aoxue Wang; Xi Liu; Florian Meisgen; Jacob Grünler; Ileana R Botusan; Sampath Narayanan; Erdem Erikci; Xi Li; Lennart Blomqvist; Lei Du; Andor Pivarcsi; Enikö Sonkoly; Kamal Chowdhury; Sergiu-Bogdan Catrina; Mona Ståhle; Ning Xu Landén
Journal:  J Clin Invest       Date:  2015-06-29       Impact factor: 14.808

6.  Overexpression of BRINP3 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration via MAP4 in Osteosarcoma.

Authors:  Wenchao Zeng; Huiya Xu; Tian Wei; Huishan Liang; Xiaokun Ma; Fen Wang
Journal:  Dis Markers       Date:  2022-07-07       Impact factor: 3.464

7.  MicroRNA-411 promoted the osteosarcoma progression by suppressing MTSS1 expression.

Authors:  Ning Xu; Weiliang Yang; Yang Liu; Feng Yan; Zhange Yu
Journal:  Environ Sci Pollut Res Int       Date:  2018-02-16       Impact factor: 4.223

8.  MicroRNA-874-mediated inhibition of the major G1/S phase cyclin, CCNE1, is lost in osteosarcomas.

Authors:  Tanushree Ghosh; Akhil Varshney; Praveen Kumar; Manpreet Kaur; Vipin Kumar; Ritu Shekhar; Raksha Devi; Priyanka Priyanka; Md Muntaz Khan; Sandeep Saxena
Journal:  J Biol Chem       Date:  2017-11-06       Impact factor: 5.157

9.  miR-132 targeting E2F5 suppresses cell proliferation, invasion, migration in ovarian cancer cells.

Authors:  Hang Tian; Lei Hou; Yu-Mei Xiong; Jun-Xiang Huang; Wen-Hua Zhang; Yong-Ying Pan; Xing-Rong Song
Journal:  Am J Transl Res       Date:  2016-03-15       Impact factor: 4.060

10.  MicroRNA-132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4.

Authors:  Yulong Liu; Ye Li; Jingchen Liu; Yuntao Wu; Qingsan Zhu
Journal:  Int J Oncol       Date:  2015-09-07       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.